Thermo Fisher will commence a tender offer to acquire all of the ordinary shares of QIAGEN. It’s largest disclosed sale occurred in 2019, when it sold Thermo Fisher Scientific - Anatomical Pathology Business to PHC Holdings for $1.1B. Talent Acquisition at Thermo Fisher Scientific( Actively looking for opportunities) Jyoti Abrol HR Lead- Multiple business teams, D&I Lead at Thermo Fisher Scientific Search Thermo Fisher Scientific Search All Search This product (Catalog number PID10123889A) has been discontinued. Thermo Fisher Scientific has acquired 57 organizations. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Thermo Fisher Scientific’s largest acquisition to date was in 2013, when it acquired Life Technologies for $15.8B. Thermo Fisher Scientific has acquired in 15 different US states, and 15 countries. Thermo Fisher signed a definitive agreement to acquire the firm for approximately $925m in June last year. The company said that the termination of the agreement was because of challenges in obtaining UK regulatory approval. Thermo Fisher Scientific has agreed to abandon the proposed acquisition of Gatan from software developer Roper Technologies. Please contact Customer Service for possible alternatives. Management announced they expect similar % growth in 2020 and revenues of ~$26.8bn. The transaction values QIAGEN at approximately $11.5 billion at current exchange rates, which includes the assumption of approximately $1.4 billion of net debt. Show They acquired Qiagen for $11.5B. Their most recent acquisition was Qiagen on Mar 3, 2020.
WALTHAM, Mass., May 1, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has completed its previously announced acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for approximately $1.7 billion in cash. Which types of acquisition does this organization make most frequently? Through the acquisition of the Epredia business from Thermo Fisher, PHCHD will strengthen its diagnostics business by expanding its portfolio into oncology to support further business growth. Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. QIAGEN Announces Publication of Reasoned Position Statement for Proposed Acquisition by Thermo Fisher and Date for Annual General Meeting Business Wire May 18, 2020 Thermo Fisher's revenue growth dipped in 2019 to 5%.